{"entity":{"type":"insider","cik":"0001273351","url":"/insider/0001273351","json_url":"/insider/0001273351.json","name":"CARR EDWARD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":4,"first":"2020-03-20","last":"2026-03-13","span_basis":"filed_date"},"name_variants":[{"name":"CARR EDWARD","source":"filing","n_filings":4,"first_seen":"2020-03-20","last_seen":"2026-03-13"}],"transactions":[{"id":6019715,"accession":"0001273351-26-000004","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001273351-26-000004","line_url":"/filing/0001273351-26-000004","is_derivative":false,"issuer_cik":"0001273351","issuer_name":"Dianthus Therapeutics, Inc. /DE/","issuer_ticker":"DNTH","issuer_name_source":null,"issuer_url":"/issuer/0001273351","owner_cik":"0001273351","owner_name":"CARR EDWARD","owner_display_name":"CARR EDWARD","owner_url":"/insider/0001273351","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43682.0,"shares_display":"43,682","price_per_share":81.48652923400944,"price_display":"81.49","price_state":"stated","total_value":3559494.57,"total_display":"3,559,494.57","total_whole":"3,559,495","shares_owned_after":4365.0,"shares_owned_after_display":"4,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-12","filed_date":"2026-03-13","scope":"insider","n_lines":5},{"id":5323636,"accession":"0001493152-21-025082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-025082","line_url":"/filing/0001493152-21-025082#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001273351","owner_name":"CARR EDWARD","owner_display_name":"CARR EDWARD","owner_url":"/insider/0001273351","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29122.0,"shares_display":"29,122","price_per_share":1.0506,"price_display":"1.05","price_state":"stated","total_value":30595.5732,"total_display":"30,595.57","total_whole":"30,596","shares_owned_after":400169.0,"shares_owned_after_display":"400,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-08","filed_date":"2021-10-08","scope":"insider"},{"id":5071263,"accession":"0001493152-21-008025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-21-008025","line_url":"/filing/0001493152-21-008025#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001273351","owner_name":"CARR EDWARD","owner_display_name":"CARR EDWARD","owner_url":"/insider/0001273351","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":1.7956,"price_display":"1.80","price_state":"stated","total_value":62846.0,"total_display":"62,846.00","total_whole":"62,846","shares_owned_after":191291.0,"shares_owned_after_display":"191,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-05","scope":"insider"},{"id":5071259,"accession":"0001493152-21-008025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-008025","line_url":"/filing/0001493152-21-008025#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001273351","owner_name":"CARR EDWARD","owner_display_name":"CARR EDWARD","owner_url":"/insider/0001273351","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20445.0,"shares_display":"20,445","price_per_share":1.8521,"price_display":"1.85","price_state":"stated","total_value":37866.1845,"total_display":"37,866.18","total_whole":"37,866","shares_owned_after":226291.0,"shares_owned_after_display":"226,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"},{"id":2314474,"accession":"0001493152-20-004438","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-004438","line_url":"/filing/0001493152-20-004438#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001273351","owner_name":"CARR EDWARD","owner_display_name":"CARR EDWARD","owner_url":"/insider/0001273351","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Abeona Therapeutics Inc. Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6446.0,"shares_display":"6,446","price_per_share":1.81,"price_display":"1.81","price_state":"stated","total_value":11667.26,"total_display":"11,667.26","total_whole":"11,667","shares_owned_after":13554.0,"shares_owned_after_display":"13,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001690585","name":"Dianthus Therapeutics, Inc. /DE/","url":"/issuer/0001690585","role":"Officer (CHIEF ACCOUNTING OFFICER)","n_filings":1,"first_seen":"2026-03-13","last_seen":"2026-03-13"},{"type":"issuer","type_label":"ISSUER","cik":"0000318306","name":"ABEONA THERAPEUTICS INC.","url":"/issuer/0000318306","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2020-03-20","last_seen":"2021-10-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001273351","retrieved_at":"2026-08-26T08:27:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}